You have 9 free searches left this month | for more free features.

Hemoglobin SC Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • MED-Go App
  • Chicago, Illinois
    Ann & Robert H Lurie Children's Hospital of Chicago
Mar 7, 2022

Hemoglobin SC Disease, Anemia, Sickle Cell Trial in Miami (Parent Educational Support)

Completed
  • Hemoglobin SC Disease
  • Anemia, Sickle Cell
  • Parent Educational Support
  • Miami, Florida
    Mailman Center for Child Development
Jul 26, 2021

Hemoglobin SC Disease Trial in Houston (hydroxyurea)

Terminated
  • Hemoglobin SC Disease
  • Houston, Texas
    Texas Children's Hospital
Sep 8, 2020

Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)

Completed
  • Sickle Cell Disease
  • +3 more
  • HU-Go app
  • Chicago, Illinois
    Ann & Robert H Lurie Children's Hospital of Chicago
Jul 27, 2021

Sickle Cell Hemoglobin C Disease, Hemoglobin S Disease Trial in France (Training Program)

Completed
  • Sickle Cell Hemoglobin C Disease
  • Hemoglobin S Disease
  • Training Program
  • Bobigny, France
  • +8 more
Sep 6, 2021

Sickle Cell Disease, Sickle Cell Hemoglobin C, Sickle Beta Zero Thalassemia Trial in Chicago (PROs assessment using sickle cell

Completed
  • Sickle Cell Disease
  • +3 more
  • PROs assessment using sickle cell disease mobile app (SCD-app)
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Dec 17, 2020

Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)

Terminated
  • Sickle Cell Disease
  • Hemoglobin SC
  • Houston, Texas
  • +1 more
Jul 16, 2020

Hemoglobin SC Disease Trial in Houston (Hydroxyurea)

Terminated
  • Hemoglobin SC Disease
  • Houston, Texas
  • +1 more
Jan 23, 2020

Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)

Recruiting
  • Alpha Thalassemia Hemoglobin H Constant Spring
  • +2 more
  • RM-004
  • Nanning, Guangxi, China
    The 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023

Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

Not yet recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Vedolizumab IV
  • Vedolizumab SC
  • (no location specified)
Oct 17, 2023

Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)

Active, not recruiting
  • Crohn's Disease
  • CT-P13 SC (Infliximab)
  • Placebo SC
  • Warszawa, Poland
    WIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Dyslipidemias, Hyperglycemia, Liver Dysfunction Trial in Karachi (Ajwa Date (phoenix dactylifera))

Unknown status
  • Dyslipidemias
  • +5 more
  • Ajwa Date (phoenix dactylifera)
  • Karachi, Sindh, Pakistan
    Aga Khan University
Nov 7, 2019

Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting
  • Sickle Cell Disease
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2023

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Crohn's Disease Trial in Seoul (Infliximab-Dyyb)

Not yet recruiting
  • Crohn's Disease
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 5, 2023

Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

Not yet recruiting
  • Diabetic Kidney Disease
  • IgA Nephropathy
  • Placebo of SC0062
  • +3 more
  • (no location specified)
Jan 9, 2023

Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)

Recruiting
  • Von Willebrand Diseases
  • Vienna, Austria
    Medical University of Vienna
Mar 20, 2023

Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)

Recruiting
  • Sickle Cell Disease
  • OTQ923
  • Los Angeles, California
  • +4 more
Jan 9, 2023

Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA

Recruiting
  • Sickle Cell Disease
  • Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
  • Los Angeles, California
  • +8 more
Jan 10, 2023

Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • HDL2
  • Pointe-à-Pitre, Guadeloupe, France
  • +1 more
Mar 21, 2023

Perianal Fistula, Crohn's Disease Trial (Human TH-SC01 cell injection)

Not yet recruiting
  • Perianal Fistula
  • Crohn's Disease
  • Human TH-SC01 cell injection
  • (no location specified)
Nov 15, 2022

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Sickle Cell Disease Trial in Atlanta (GBT021601)

Active, not recruiting
  • Sickle Cell Disease
  • Atlanta, Georgia
  • +1 more
Aug 10, 2022